Myocardial Solutions
Medical Devices, 808 Aviation Pkwy, Morrisville, North Carolina, 27560, United States, 11-50 Employees
Phone Number: 91********
Who is MYOCARDIAL SOLUTIONS
Myocardial Solutions, Inc. (MSI) is a medical technology company working to transform the cardiac and cancer care continuum. Leveraging more than 400 publications in clinical research and...
Read More
-
Headquarters: 808 Aviation Pkwy, Morrisville, North Carolina, 27560, United States
-
Date Founded: 2016
-
Employees: 11-50
-
Revenue: $5 Million to $10 Million
-
Active Tech Stack: See technologies
Industry: Medical Devices
SIC Code: 8071
|
NAICS Code: 621512 |
Show More
Does something look wrong? Fix it. | View contact records from MYOCARDIAL SOLUTIONS
Myocardial Solutions Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Myocardial Solutions
Answer: Myocardial Solutions's headquarters are located at 808 Aviation Pkwy, Morrisville, North Carolina, 27560, United States
Answer: Myocardial Solutions's phone number is 91********
Answer: Myocardial Solutions's official website is https://myocardialsolutions.com
Answer: Myocardial Solutions's revenue is $5 Million to $10 Million
Answer: Myocardial Solutions's SIC: 8071
Answer: Myocardial Solutions's NAICS: 621512
Answer: Myocardial Solutions has 11-50 employees
Answer: Myocardial Solutions is in Medical Devices
Answer: Myocardial Solutions contact info: Phone number: 91******** Website: https://myocardialsolutions.com
Answer: Myocardial Solutions, Inc. (MSI) is a medical technology company working to transform the cardiac and cancer care continuum. Leveraging more than 400 publications in clinical research and development, MSIs proprietary technology, MyoStrain, is a 10-minute, non-invasive heart function test providing physicians with sensitive diagnostic markers to support the early assessment and individualized treatment of heart dysfunction. This novel cardiac tool leverages the power of high-speed MR imaging to help physicians detect and measure the effects of cardiotoxicity during cancer treatments. Physicians are using MyoStrain as a critical solution to holistically evaluate and protect patient heart health without interfering with oncology care. Today, with mounting evidence that many oncology treatments cause cardiotoxicity, new cancer patients and survivors are at an increased risk of cardiovascular disease. Unfortunately, diagnostics often cannot detect cardiotoxicity until symptoms occur, which is usually a sign of cardiac damage. The MyoStrain test works by quantifying segmental strain across 48 segments of the heart. This safe and rapid test produces a comprehensive report and MyoHealthTM Score, a single number that helps indicate patient heart health and enables physicians to manage cardio-protection over time. MyoStrain has received FDA-510(k) pre-market clearance, CE-mark certification, and is commercially available in the United States and Europe.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month